Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1603: TNFR2+ regulatory T cells are key players in immune escape in gastric tumor microenvironment

View through CrossRef
Abstract BACKGROUND & AIMS: Regulatory T cells (Tregs) are potent immunosuppressive cells of the immune system. It is reported that the expression of TNFR2 identifies a subpopulation of Tregs with the maximally suppressive function. Thus, understanding the heterogeneity of human CD4+FOXP3+ Tregs and the function of TNFR2+ Tregs is of critical importance for moving Treg therapy into the clinics. METHODS: The expression phenotype of TNFR2+ Tregs from gastric cancer patients and normal controls were detected by flow cytometry. Further, we quantified the infiltrated Foxp3+ Tregs and TNFR2+ Tregs of gastric cancer patients using multicolor immunofluorescence assay. Moreover, to generate a deep transcriptional map of the Tregs in human gastric cancer, we profiled 9058 Tregs from three gastric carcinomas, as well as 16769 Tregs from matched peripheral blood mononuclear cells (PBMCs), using single-cell RNA-seq. RESULTS: In the peripheral blood of gastric cancer patients and healthy individuals, Tregs expressed markedly higher levels of TNFR2 than conventional T cells (Tconvs). The proportion of total FoxP3+ Tregs in the CD4+ cells and the percentage of TNFR2+ Tregs increased with tumor progression and lymphatic metastasis. Analysis of single-cell RNA sequencing data revealed that Tregs in gastric carcinomas microenvironment exhibited dissimilar phenotypes compared with Tregs in matched PBMCs. We observed lower phenotypic heterogeneity of tumor-derived Tregs. Tumor infiltrating Tregs expressed higher levels of immune checkpoint genes compared with peripheral blood Tregs, indicating they were in more activated states. Besides, we found the expression level of TNFR2 in two tumor-derived clusters was much higher compared with others. Treg biomarkers and immune checkpoint genes were also highly expressed in these two populations, suggesting that they were the main immunosuppressive Treg proportions in tumor microenvironment. Gene enrichment analysis indicated that the two Treg populations showed an overlap of gene expression signatures of Th1, Th2, and Th17 cells, which was consistent with the increasing evidence that Tregs can exhibit helper T cell-like phenotype to promote Tregs migrating and suppressing immune response. CONCLUSIONS: Our findings revealed that TNFR2 could be a promising molecular marker associated with poor prognosis of patients baring gastric cancer. We also established the heterogeneity at the single-cell level of CD4+FOXP3+ Tregs, explaining the remarkable complexity and functional diversity of human Tregs. Finally, our work provide important clues for exploring the mechanism by which TNFR2 regulates the phenotype and activity of Tregs in the tumor microenvironment. Citation Format: Liling Niu. TNFR2+ regulatory T cells are key players in immune escape in gastric tumor microenvironment [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 1603.
American Association for Cancer Research (AACR)
Title: Abstract 1603: TNFR2+ regulatory T cells are key players in immune escape in gastric tumor microenvironment
Description:
Abstract BACKGROUND & AIMS: Regulatory T cells (Tregs) are potent immunosuppressive cells of the immune system.
It is reported that the expression of TNFR2 identifies a subpopulation of Tregs with the maximally suppressive function.
Thus, understanding the heterogeneity of human CD4+FOXP3+ Tregs and the function of TNFR2+ Tregs is of critical importance for moving Treg therapy into the clinics.
METHODS: The expression phenotype of TNFR2+ Tregs from gastric cancer patients and normal controls were detected by flow cytometry.
Further, we quantified the infiltrated Foxp3+ Tregs and TNFR2+ Tregs of gastric cancer patients using multicolor immunofluorescence assay.
Moreover, to generate a deep transcriptional map of the Tregs in human gastric cancer, we profiled 9058 Tregs from three gastric carcinomas, as well as 16769 Tregs from matched peripheral blood mononuclear cells (PBMCs), using single-cell RNA-seq.
RESULTS: In the peripheral blood of gastric cancer patients and healthy individuals, Tregs expressed markedly higher levels of TNFR2 than conventional T cells (Tconvs).
The proportion of total FoxP3+ Tregs in the CD4+ cells and the percentage of TNFR2+ Tregs increased with tumor progression and lymphatic metastasis.
Analysis of single-cell RNA sequencing data revealed that Tregs in gastric carcinomas microenvironment exhibited dissimilar phenotypes compared with Tregs in matched PBMCs.
We observed lower phenotypic heterogeneity of tumor-derived Tregs.
Tumor infiltrating Tregs expressed higher levels of immune checkpoint genes compared with peripheral blood Tregs, indicating they were in more activated states.
Besides, we found the expression level of TNFR2 in two tumor-derived clusters was much higher compared with others.
Treg biomarkers and immune checkpoint genes were also highly expressed in these two populations, suggesting that they were the main immunosuppressive Treg proportions in tumor microenvironment.
Gene enrichment analysis indicated that the two Treg populations showed an overlap of gene expression signatures of Th1, Th2, and Th17 cells, which was consistent with the increasing evidence that Tregs can exhibit helper T cell-like phenotype to promote Tregs migrating and suppressing immune response.
CONCLUSIONS: Our findings revealed that TNFR2 could be a promising molecular marker associated with poor prognosis of patients baring gastric cancer.
We also established the heterogeneity at the single-cell level of CD4+FOXP3+ Tregs, explaining the remarkable complexity and functional diversity of human Tregs.
Finally, our work provide important clues for exploring the mechanism by which TNFR2 regulates the phenotype and activity of Tregs in the tumor microenvironment.
Citation Format: Liling Niu.
TNFR2+ regulatory T cells are key players in immune escape in gastric tumor microenvironment [abstract].
In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24.
Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 1603.

Related Results

Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane‐bound TNF in experimental cerebral malaria
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane‐bound TNF in experimental cerebral malaria
AbstractTumor necrosis factor (TNF) has been implicated in the pathogenesis of experimental cerebral malaria (CM), but the respective role of its two types of receptors has not bee...
The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
Colorectal cancer (CRC) represents one of the most common causes of death among cancers worldwide. Its incidence has been increasing among the young population. Many risk factors c...
TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects
TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects
Several autoimmune diseases are marked by a deficiency of soluble tumor necrosis factor (TNF). The TNF deficiency is caused in at least one autoimmune disease, multiple sclerosis, ...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract Introduction Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Defining heterogeneity in the immune infiltrate of gastroesophageal adenocarcinoma
Defining heterogeneity in the immune infiltrate of gastroesophageal adenocarcinoma
Gastro-esophageal adenocarcinoma (GEAC) is a cancer with a poor prognosis and limited treatment options. Most patients present with metastatic disease, where systemic therapies off...
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Abstract Background Aquaporin 3(AQP3) has been implicated in gastric intestinal metaplasia and gastric cancer, and considered as a biomarker to improve treatment strategy....
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...

Back to Top